| Danny Schust, MD | |
|
500 N Keene St Ste 203, Columbia, MO 65201-8144 | |
| (573) 882-8173 | |
| (573) 499-6065 |
| Full Name | Danny Schust |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Reproductive Endocrinology |
| Location | 500 N Keene St Ste 203, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619950821 | NPI | - | NPPES |
| 201465606 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2006020246 (Missouri) | Secondary |
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 2006020246 (Missouri) | Primary |
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Massachusetts General Hospital (MGH) investigators have induced structures incorporated within individual cells to produce laser light.
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery-a life-threatening condition known as pulmonary embolism.
The American Academy of Family Physicians' Family Practice Management Journal has released a new report outlining physician coercion when switching EHRs. The survey shows doctors are being forced to switch EHRs and points to widespread dissatisfaction among physicians who've switched.
Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.
› Verified 1 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Massachusetts General Hospital (MGH) investigators have induced structures incorporated within individual cells to produce laser light.
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery-a life-threatening condition known as pulmonary embolism.
The American Academy of Family Physicians' Family Practice Management Journal has released a new report outlining physician coercion when switching EHRs. The survey shows doctors are being forced to switch EHRs and points to widespread dissatisfaction among physicians who've switched.
Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny Schust, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Danny Schust, MD 500 N Keene St Ste 203, Columbia, MO 65201-8144 Ph: (573) 882-8173 |
News Archive
Massachusetts General Hospital (MGH) investigators have induced structures incorporated within individual cells to produce laser light.
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery-a life-threatening condition known as pulmonary embolism.
The American Academy of Family Physicians' Family Practice Management Journal has released a new report outlining physician coercion when switching EHRs. The survey shows doctors are being forced to switch EHRs and points to widespread dissatisfaction among physicians who've switched.
Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.
› Verified 1 days ago
Rose Elizabeth Todd, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Lindsey Taylor Ellis, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St # Dc570.00, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Madalyn Michelle Barnett, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Abby Marie Lombardi, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St # Dc570.00, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Kaley Holloway Hankins, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 402 N Keene St, Columbia, MO 65201 Phone: 573-499-6084 Fax: 573-499-6088 | |
Dr. Michael S Cardwell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 500 N. Keene St, Suite 406, Columbia, MO 65201 Phone: 573-499-6041 Fax: 573-499-6091 | |
Breton Foster Barrier, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2325 Smiley Ln, Columbia, MO 65202 Phone: 573-817-3535 Fax: 573-817-3536 |